StockData
Monopar Therapeutics logo

Monopar Therapeutics (MNPR) shareholders

MNPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$72.00−0.68 (-0.94%)

Close on Nov 13, 2026Market cap $483.28MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
92.7%
6M of 7M shares
Institutional holders
96
30 new, 14 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
1 buys · 36 sales
Net sold $5.57M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Janus Henderson Group PLC
Joint filing with Janus Henderson Biotech Innovation Master Fund Ltd (16.70%)
1,287,36819.50%13G (passive) amendmentSep 30, 2025
Peter Kolchinsky
Joint filing with RA Capital Management, L.P. (9.90%), Rajeev Shah (9.90%) and 1 more
742,8619.90%13G (passive) amendmentSep 30, 2025
Rajeev Shah
Joint filing with RA Capital Management, L.P. (9.90%), Peter Kolchinsky (9.90%) and 1 more
667,6329.90%13G (passive) amendmentDec 31, 2025
AstraZeneca PLC
Joint filing with Alexion Pharmaceuticals, Inc. (7.80%)
522,6677.80%13G (passive) amendmentDec 31, 2025
Robert Atchinson
Joint filing with Adage Capital Management, L.P. (6.23%), Phillip Gross (6.23%)
424,1956.23%13G (passive) amendmentMar 31, 2026
Xiaoying Tian
Joint filing with Saturn V Capital Management LP (5.20%)
345,6265.20%13G (passive)Jan 5, 2026
BlackRock, Inc.338,1335.03%13G (passive)Sep 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of MNPRValueChange% of portfolio
Jupiter Topco LLC1,312,12919.55%$121.70MNew0.05%
Ra Capital Management, L.P.667,2079.94%$61.78M–0.54%
BlackRock, Inc.348,8195.20%$32.30M+32,2520.00%
Deerfield Management Company, L.P. (Series C)323,7454.82%$29.98M–0.31%
Saturn V Capital Management LP311,9764.65%$28.89M−33,6504.14%
Siren, L.L.C.270,1184.02%$25.01M–0.51%
ADAR1 Capital Management, LLC217,5953.24%$20.15M−46,6830.92%
Polar Capital Holdings Plc214,4693.20%$19.86M−12,0570.05%
Vanguard Capital Management LLC209,7113.12%$19.42M−8,7520.00%
Adage Capital Partners Gp, L.L.C.209,1953.12%$19.37M−100,0000.03%
TCG Crossover Management, LLC203,3273.03%$18.83M+71,2240.45%
Wellington Management Group Llp158,4372.36%$14.67M−15,9050.00%
Orbimed Advisors LLC157,4232.35%$14.58MNew0.27%
Candriam S.C.A.143,3392.14%$13.26MNew0.06%
Balyasny Asset Management L.P.134,5432.00%$12.46M−1,9000.02%
Geode Capital Management, LLC112,5781.68%$10.43M+12,6600.00%
Alyeska Investment Group, L.P.100,0001.49%$9.26M–0.02%
State Street Corp92,5511.38%$8.57M+4,1960.00%
Vivo Capital, LLC90,5001.35%$8.38M–0.77%
Driehaus Capital Management LLC84,0401.25%$7.78M+50,8840.05%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026966M92.7%30 / 3224 / 142M1M
Q1 2026826M92.9%20 / 3318 / 112M1M
Q4 2025746M82.3%23 / 3210 / 51M0M
Q3 2025564M64.6%16 / 1914 / 31M0M
Q2 2025433M47.3%19 / 154 / 110M0M
Q1 2025353M43.0%18 / 65 / 10M0M
Q4 2024183M38.4%12 / 31 / 03M0M
Q3 202460M0.2%6 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

98 funds held MNPR in Q2 2026, 67% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of MNPRValue% of fundAs of
Vanguard Total Stock Market Index Fund159,7862.38%$14.79M0.00%Jun 30, 2026
iShares Russell 2000 ETF118,7001.77%$10.99M0.01%Jun 30, 2026
Fidelity Small Cap Index Fund49,3320.73%$5.35M0.02%Jul 31, 2026
Vanguard Extended Market Index Fund44,3110.66%$4.10M0.00%Jun 30, 2026
iShares Russell 2000 Value ETF31,7510.47%$2.94M0.02%Jun 30, 2026
Neuberger Small Cap Growth Fund25,3130.38%$1.65M0.24%May 31, 2026
BNY Mellon Small/Mid Cap Growth Fund23,8900.36%$2.21M0.25%Jun 30, 2026
Vanguard Russell 2000 Index Fund22,7280.34%$1.48M0.01%May 31, 2026
Fidelity Extended Market Index Fund20,4970.31%$1.33M0.00%May 31, 2026
Vanguard U.S. Momentum Factor ETF19,7670.29%$1.29M0.07%May 31, 2026
iShares Micro-Cap ETF15,1480.23%$1.40M0.09%Jun 30, 2026
Schwab Small-Cap Index Fund10,9530.16%$1.19M0.02%Jul 31, 2026
iShares Russell 2000 Growth ETF10,4650.16%$968.95K0.01%Jun 30, 2026
Master Small Cap Index Series7,7370.12%$716.37K0.01%Jun 30, 2026
Fidelity Total Market Index Fund7,1920.11%$467.77K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Chandler RobinsonChief Executive Officer, Director166,9422.49%Oct 20, 2026
Pharma LLC TacticChief Executive Officer, Director, 10% owner4,383,29965.30%Sep 26, 2025
Quan Anh VuChief Financial Officer2,6550.04%Oct 2, 2026
Andrew CittadineChief Operating Officer58,0540.86%Oct 2, 2026
Susan RodriguezCCSO––Mar 4, 2026
Kim R. TsuchimotoDirector11,4860.17%Nov 4, 2026
Raymond AndersonDirector5,3730.08%Nov 4, 2026
Christopher M. StarrDirector15,0530.22%Oct 5, 2026
Nicole SweenyDirector––Jun 30, 2026
Arthur J. KlausnerDirector3,064,15645.65%Dec 19, 2025
Lavina TalukdarDirector14,0010.21%Dec 8, 2025
Patrice Rioux–5,0660.08%Aug 27, 2026
Diane Hendricks10% owner567,5808.46%Dec 17, 2025
Thomas V. O'Halloran–4,402,94065.60%Sep 26, 2025
Andrew Paul Mazar–188,7922.81%Sep 26, 2025
Michael J. Brown–4,933,52873.50%Sep 26, 2025
LLC TacticGem10% owner0–Dec 17, 2024

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Kim R. Tsuchimoto
Director
Nov 4, 2026Sale(10b5-1 plan)−600$72.21$43.33K0
Kim R. Tsuchimoto
Director
Nov 4, 2026Sale(10b5-1 plan)−996$71.35$71.06K600
Kim R. Tsuchimoto
Director
Nov 4, 2026Sale(10b5-1 plan)−1,295$70.75$91.62K1,596
Kim R. Tsuchimoto
Director
Nov 4, 2026Option exercise+2,035$14.00$28.49K2,891
Kim R. Tsuchimoto
Director
Nov 4, 2026Option exercise+856$30.00$25.68K856
Raymond Anderson
Director
Nov 2, 2026Sale(10b5-1 plan)−1,502$70.04$105.20K5,373
Raymond Anderson
Director
Nov 2, 2026Sale(10b5-1 plan)−200$68.68$13.74K6,875
Raymond Anderson
Director
Nov 2, 2026Sale(10b5-1 plan)−600$67.06$40.24K7,075
Raymond Anderson
Director
Nov 2, 2026Sale(10b5-1 plan)−840$66.16$55.57K7,675
Raymond Anderson
Director
Nov 2, 2026Option exercise+1,740$30.00$52.20K8,515
Raymond Anderson
Director
Nov 2, 2026Option exercise+1,402$30.00$42.06K6,775
Kim R. Tsuchimoto
Director
Nov 2, 2026Sale(10b5-1 plan)−1,199$70.10$84.05K0
Kim R. Tsuchimoto
Director
Nov 2, 2026Option exercise+1,199$30.00$35.97K1,199
Chandler Robinson
Chief Executive Officer, Director
Oct 20, 2026Tax withholding−597$92.59$55.28K104,127
Christopher M. Starr
Director
Oct 1, 2026Sale(10b5-1 plan)−799$79.67$63.66K5,173
Christopher M. Starr
Director
Oct 1, 2026Sale(10b5-1 plan)−2,970$78.82$234.10K5,972
Christopher M. Starr
Director
Oct 1, 2026Sale(10b5-1 plan)−4,631$78.09$361.63K8,942
Christopher M. Starr
Director
Oct 1, 2026Option exercise+8,400$0.01$4213,573
Andrew Cittadine
Chief Operating Officer
Sep 30, 2026Tax withholding−1,944$79.67$154.88K58,054
Andrew Cittadine
Chief Operating Officer
Sep 30, 2026Option exercise+4,384––59,998
Chandler Robinson
Chief Executive Officer, Director
Sep 30, 2026Tax withholding−4,344$79.67$346.09K104,724
Chandler Robinson
Chief Executive Officer, Director
Sep 30, 2026Option exercise+9,801––109,068
Quan Anh Vu
Chief Financial Officer
Sep 30, 2026Tax withholding−180$79.67$14.34K2,655
Quan Anh Vu
Chief Financial Officer
Sep 30, 2026Option exercise+614––2,835
Chandler Robinson
Chief Executive Officer, Director
Sep 24, 2026Option exercise+15,000$14.00$210.00K128,323
Chandler Robinson
Chief Executive Officer, Director
Sep 24, 2026Option exercise+14,056$30.00$421.68K113,323
Chandler Robinson
Chief Executive Officer, Director
Sep 24, 2026Sale(10b5-1 plan)−10,450$87.15$910.72K117,873
Chandler Robinson
Chief Executive Officer, Director
Sep 24, 2026Sale(10b5-1 plan)−9,638$87.96$847.76K108,235
Chandler Robinson
Chief Executive Officer, Director
Sep 24, 2026Sale(10b5-1 plan)−8,368$88.97$744.50K99,867
Chandler Robinson
Chief Executive Officer, Director
Sep 24, 2026Sale(10b5-1 plan)−600$89.79$53.87K99,267
Kim R. Tsuchimoto
Director
Aug 26, 2026Sale(10b5-1 plan)−1,098$111.84$122.80K1,192
Kim R. Tsuchimoto
Director
Aug 26, 2026Option exercise+2,055$30.00$61.65K2,055
Kim R. Tsuchimoto
Director
Aug 26, 2026Option exercise+2,035$14.00$28.49K4,090
Kim R. Tsuchimoto
Director
Aug 26, 2026Sale(10b5-1 plan)−485$108.83$52.78K3,605
Kim R. Tsuchimoto
Director
Aug 26, 2026Sale(10b5-1 plan)−615$109.56$67.38K2,990
Kim R. Tsuchimoto
Director
Aug 26, 2026Sale(10b5-1 plan)−590$113.84$67.17K0
Kim R. Tsuchimoto
Director
Aug 26, 2026Sale(10b5-1 plan)−602$112.93$67.98K590
Kim R. Tsuchimoto
Director
Aug 26, 2026Sale(10b5-1 plan)−700$110.65$77.46K2,290
Patrice Rioux
–
Aug 26, 2026Option exercise+1,380$0.01$145,066
Patrice Rioux
–
Aug 26, 2026Sale(10b5-1 plan)−1$111.26$1115,065
Kim R. Tsuchimoto
Director
Aug 26, 2026Sale(10b5-1 plan)−485$108.83$52.78K11,001
Kim R. Tsuchimoto
Director
Aug 26, 2026Sale(10b5-1 plan)−590$113.84$67.17K7,396
Kim R. Tsuchimoto
Director
Aug 26, 2026Sale(10b5-1 plan)−615$109.56$67.38K10,386
Kim R. Tsuchimoto
Director
Aug 26, 2026Sale(10b5-1 plan)−700$110.65$77.46K9,686
Kim R. Tsuchimoto
Director
Aug 26, 2026Sale(10b5-1 plan)−1,098$111.84$122.80K8,588
Kim R. Tsuchimoto
Director
Aug 26, 2026Sale(10b5-1 plan)−602$112.93$67.98K7,986
Raymond Anderson
Director
Aug 25, 2026Sale(10b5-1 plan)−1,802$113.05$203.72K5,373
Raymond Anderson
Director
Aug 25, 2026Sale(10b5-1 plan)−694$110.04$76.37K7,821
Raymond Anderson
Director
Aug 25, 2026Option exercise+1,740$30.00$52.20K8,515
Raymond Anderson
Director
Aug 25, 2026Option exercise+1,402$30.00$42.06K6,775
Raymond Anderson
Director
Aug 25, 2026Sale(10b5-1 plan)−646$111.07$71.75K7,175
Raymond Anderson
Director
Aug 25, 2026Sale(10b5-1 plan)−1,802$113.05$203.72K23,751
Raymond Anderson
Director
Aug 25, 2026Sale(10b5-1 plan)−646$110.07$71.11K25,523
Raymond Anderson
Director
Aug 25, 2026Sale(10b5-1 plan)−694$110.04$76.37K26,169
Andrew Cittadine
Chief Operating Officer
Jun 30, 2026Option exercise+5,254––57,923
Andrew Cittadine
Chief Operating Officer
Jun 30, 2026Tax withholding−2,309$92.59$213.79K55,614
Quan Anh Vu
Chief Financial Officer
Jun 30, 2026Tax withholding−507$92.59$46.94K2,221
Quan Anh Vu
Chief Financial Officer
Jun 30, 2026Option exercise+1,228––2,728
Chandler Robinson
Chief Executive Officer, Director
Jun 30, 2026Tax withholding−4,084$92.59$378.14K99,267
Chandler Robinson
Chief Executive Officer, Director
Jun 30, 2026Option exercise+12,873––103,351

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
16.44%
1M shares short
Days to cover
8.8
At 0M shares a day
Change since last report
-2.2%
From 1M shares
Short volume, 20 days
56.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Monopar Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,507 shares on Sep 3, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Christopher M. Starr
Director
Oct 1, 202616,800$1.34MOct 1, 2026Exercise of Stock Options
Chandler Robinson
Director, Officer
Sep 24, 202629,056$2.60MSep 24, 2026Exercise of Stock Options
Patrice Rioux
Acting Chief Medical Officer
Aug 26, 20261$111Aug 26, 2026Exercise of Stock Options
Kim R. Tsuchimoto
Director
Aug 26, 20268,180$906.51KAug 26, 2026Exercise of Stock Options
Raymond Anderson
Director
Aug 25, 20266,284$699.79KAug 25, 2026Exercise of Stock Options
Arthur J. Klausner
Former Board Member
Jul 10, 20265,000$476.97KJul 8, 2026Restricted Stock Unit Vesting
Arthur J. Klausner
Employer
Jul 7, 20265,000$485.25KJul 7, 2026LP in LLC
Arthur J. Klausner
Board Member
Dec 19, 20255,121$343.90KDec 18, 2025LP in LLC
Kim R. Tsuchimoto
Director
Jul 14, 20258,904$356.16KJul 14, 2025Stock Option Exercise
Chandler Robinson
Officer, Director
Jul 14, 202516,800$672.00KJul 14, 2025Stock Option Exercise
Christopher M. Starr
Director
Jul 14, 202516,800$672.00KJul 14, 2025Stock Option Exercise
Pharma LLC Tactic
10% Stockholder
Apr 2, 202533,334$1.17MApr 2, 2025Private Placement

See a number that looks wrong?